Advanced Search
Contact | Corporate | Help

Lucentis (Ranibizumab) for Eales' Disease

Sponsors:
  • Oregon Health and Science University
  • Genentech
Phases:
  • Phase II
  • Phase III
IndicationsAcronym:
  • Eales' Disease
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ranibizumab
Enrollment:
5

Additional information about NCT00384449.


SourceSolution © 2008-2012